Drug
SR Mitomycin Intravesical Solution clinical trials
- studies test it
- 4
- open now
- 0
- in phase 3
- 3
- first study started
- 2018
How studies write it
Studies that test it under each name
Combined with it in one product
Studies by the year they started
4 studies that test it; most in 2021 (2)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2021 | 2 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 1
- Phase 3
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
UroGen Pharma Ltd. (4)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses SR Mitomycin Intravesical Solution is read from its arms, and is right about nine times in ten.
Testing it · 4
- A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder CancerActive, not recruitingPhase 3UroGen Pharma Ltd.NCT05243550Written as UGN-102
- Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC)CompletedPhase 3UroGen Pharma Ltd.NCT05136898Written as UGN-102
- A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder CancerTerminatedPhase 3UroGen Pharma Ltd.NCT04688931Written as UGN-102
- A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder CancerCompletedPhase 2UroGen Pharma Ltd.NCT03558503Written as UGN-102